Seeking Alpha

In a first for a major pharma company, GlaxoSmithKline (GSK) will make detailed data from its...

In a first for a major pharma company, GlaxoSmithKline (GSK) will make detailed data from its clinical trials available to other researchers from the start of next year. GSK's pledge comes three months after it agreed to pay a record $3B fine in the U.S. for providing misleading information on some drugs. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)